Grants / Department of Health and Human Services / Centers for Disease Control and Prevention - ERA

RFA-IP-23-001: Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Pathogens in China

Closed Closed February 9, 2023 Opportunity RFA-IP-23-001 ☆ Save

This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control and Prevention - ERA notices from 2022.

• Award ceiling$350,000
• Award floor$250,000
• Total funding$4.3 million
• Expected awards1
• Cost sharingNot required
• Funding typeCooperative Agreement

Key dates

Who can apply

This opportunity was open to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses.

The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Nonprofits (Other than Institutions of Higher Education) Eligible Agencies of the Federal Government Faith-based or Community-based Organizations U.S. Territory or Possession Regional Organizations Bona Fide Agents: A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with "Other Attachment Forms" when submitting via https://www.grants.gov Federally Funded Research and Development Centers (FFRDCs): FFRDCs are operated, managed, and/or administered by a university or consortium of universities, other not-for-profit or nonprofit organization, or an industrial firm, as an autonomous organization or as an identifiable separate operating unit of a parent organization. A FFRDC meets some special long-term research or development need which cannot be met as effectively by an agency’s existing in-house or contractor resources. FFRDC’s enable agencies to use private sector resources to accomplish tasks that are integral to the mission and operation of the sponsoring agency. For more information on FFRDCs, go to https://gov.ecfr.io/cgi-bin/searchECFR Foreign Organizations: a Foreign Organization is a public or private organization, whether non-profit or for-profit, located in a country other than the United States (U.S.) and its territories that is subject to the laws of the country in which it is located, irrespective of the citizenship of project staff or place of performance.

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses.

Is this a realistic fit?

• Past Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases awards averaged $1.9 million; this notice allows up to $350,000 per award.
• Most of the program's money (84% over five years) went to nonprofits.
• No cost sharing or match is required.

What the grant funds

The purpose of this Notice of Funding Opportunity (NOFO) is to support enhanced surveillance and applied research for influenza virus and other respiratory infections in humans and animals in China. This work should help to: 1) better define the global risk of novel avian, non-avian, and seasonal influenza viruses and other respiratory diseases in China; and 2) build the evidence base for the prevention and control of these diseases. The scope of research performed should include, but is not limited to: a) activities for estimating the burden and cost of illness for groups at high risk for severe disease; b) monitoring vaccine uptake and efficacy; c) promoting vaccine programs for groups at high risk for severe influenza complications; and d) conducting surveillance for detection and control of novel and seasonal influenza viruses and other respiratory pathogens. Research activities for the prevention and control of novel and seasonal influenza viruses and other respiratory pathogens and pandemic preparedness activities should be aimed at preventing and controlling the spread and transmission of these diseases within China, and potentially to other countries, including the United States. Continued monitoring, detection, and reporting of these diseases in China should advance efforts to inform global health infection control policies and prevent and control seasonal epidemic and pandemic influenza in countries around the world. This NOFO provides an opportunity to conduct research in these important areas.

Category: Health.

Applying now

This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.